Cardiology

The updated vaccine is expected to be available in time for the fall 2026 provincial and territorial vaccination campaigns.

Study evaluates GLP-1 RA versus SGLT2 inhibitor use and all-cause mortality and major adverse cardiovascular events in adults with and without serious mental illness.

Test your knowledge of the important biomarker, from diagnostic thresholds to common interpretation pitfalls.

The Canadian Cardiovascular Society worked with other groups to put out resource for healthcare professionals while the ACE inhibitor is in short supply.

Test your knowledge on the basics of prescribing and adjusting antihypertensive medications.

Test your knowledge on the basics of prescribing and adjusting antihypertensive medications.

INESSS is updating its national medical protocol and group prescription template for medication adjustment and monitoring in adults with primary hypertension, and releasing a new guide for clinicians.

Here is a familiar primary care moment: a patient comes in for something else, their blood pressure is high, and suddenly everyone has homework.

McMaster researchers say the next step is to block the cause of these side effects without compromising the benefits of the drug.

Canadian researchers examine whether thromboprophylaxis with low-dose ASA alone is inferior to five days of rivaroxaban followed by ASA after total hip/knee arthroplasty.